Brand
Nostrum Laboratories, Inc.
1 federal recall on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for Nostrum Laboratories, Inc. and translate it into plain English — free weekly digest, optional same-day alerts.
- 2025-08-06FDA-DrugClass IISucralfate Tablets, USP 1 gram, packaged in a) 100-count bottles NDC 29033-0003-01, and b) 500-count bottles, NDC 29033-0003-05), Rx Only, Manufactured by: Nostrum Laboratories, Inc., Kansas City, MO 64120.
CGMP Deviations: The recalling firm filed for Chapter 11 in September 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.
Get notified about new Nostrum Laboratories, Inc. recalls
Free weekly digest. We email when a new federal recall affects Nostrum Laboratories, Inc. or anything else in your household.
Get the Sunday BriefExplore other recall topics
By hazard
By state